P. Andersen

发表

Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome

K. Birkeland, H. Arnesen, I. Seljeflot, 1995 .

Increased Fibrinolytic Capacity after Intervention on Diet in Healthy Coronary High‐risk Men

I. Hjermann, H. Arnesen, P. Andersen, 2009 .

Hyperlipoproteinaemia and reduced fibrinolytic activity in healthy coronary high-risk men.

I. Hjermann, H. Arnesen, P. Andersen, 2009, Acta medica Scandinavica.

Hyperlipidaemia and reduced fibrinolytic activity associated with thromboembolic complications in a family.

P. Andersen, 2009, Acta medica Scandinavica.

Effects of Gemfibrozil on Lipids and Haemostasis after Myocardial Infarction

H. Arnesen, I. Seljeflot, Pål J. Smith, 1990, Thrombosis and Haemostasis.

Effects of doxazosin and atenolol on atherothrombogenic risk profile in hypertensive middle-aged men.

I. Holme, I. Hjermann, H. Arnesen, 1998, Journal of cardiovascular pharmacology.

The antiheparin effect of alpha 1-acid glycoprotein: influence on heparin tolerance during the acute phase reaction.

P. Kierulf, H. Godal, P. Andersen, 1981, Thrombosis research.

Crossed radioimmunoelectrophoresis in the study of thrombin-binding proteins in human plasma.

L. Aukrust, P. Andersen, O. Grimmer, 1980, Thrombosis research.

The antiheparin effect of alpha1-acid glycoprotein probably due to steric hindrance of the heparin-thrombin interaction.

H. Godal, P. Andersen, 1979, Thrombosis research.

Global fibrinolytic capacity assessed by the serum D-dimer test. Correlation between basal and stimulated values.

H. Arnesen, I. Seljeflot, J. Eritsland, 1994, Thrombosis research.

Increased fibrinolytic potential after diet intervention in healthy coronary high-risk individuals.

I. Holme, I. Hjermann, D. Nilsen, 2009, Acta Medica Scandinavica.

Predictable reduction in anticoagulant activity of warfarin by small amounts of vitamin K.

H. Godal, P. Andersen, 2009, Acta medica Scandinavica.

The antithrombin and antiheparin effects of crude and highly purified α1-acid glycoprotein

P. Kierulf, H. Godal, P. Andersen, 1980 .

Hypercoagulability and Reduced Fibrinolysis in Hyperlipidemia: Relationship to the Metabolic Cardiovascular Syndrome

P. Andersen, 1992, Journal of cardiovascular pharmacology.

Reduced Fibrinolytic Capacity Associated with Low Ratio of Serum Testosterone to Oestradiol in Healthy Coronary High‐risk Men

I. Hjermann, P. Andersen, N. Norman, 2009 .

D-dimer Agglutination Test in the Evaluation of Fibrinolytic Capacity after Stimulation with DDAVP

H. Arnesen, I. Seljeflot, P. Smith, 1990 .

The antiheparin effect of alpha 1-acid glycoprotein, evaluated by the activated partial thromboplastin time and by a factor Xa assay for heparin.

P. Andersen, 1980, Haemostasis.

The anticoagulant effect of heparin + antithrombin III using purified fibrinogen as substrate.

H. Godal, P. Andersen, 1977, Haemostasis.

Thrombin‐, Epinephrine‐ and Collagen‐Induced Platelet Aggregation Inhibited by α1‐Acid Glycoprotein

C. Eika, P. Andersen, 2009 .

The euglobulin clot lysis time, a rapid and sensitive method for the assay of fibrinolytic activity after venous stasis.

H. Arnesen, H. Godal, P. Andersen, 2009, Scandinavian journal of haematology.

Reduced antiheparin effect of desialyzed α1-acid glycoprotein

F. Brosstad, P. Andersen, S. Andersen, 1980 .

The antiheparin effect of alpha1-acid glycoprotein and platelet material, evaluated by the heparin thrombin clotting time.

H. Godal, P. Andersen, 1977, Haemostasis.

Inhibition of thrombin-induced platelet aggregation by crude and highly purified alpha 1-acid glycoprotein.

C. Eika, P. Andersen, 2009, Scandinavian journal of haematology.

Effects of doxazosin and atenolol on circulating endothelin-1 and von Willebrand factor in hypertensive middle-aged men.

H. Arnesen, T. Aspelin, I. Seljeflot, 1999, Journal of cardiovascular pharmacology.

Heparin Tolerance Determinating Factors Evaluated by the Heparin Thrombin Clotting Time

H. Godal, P. Andersen, 1977, Thrombosis and Haemostasis.

Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome.

K. Birkeland, H. Arnesen, I. Seljeflot, 1994, Metabolism: clinical and experimental.

A comparative study of venous occlusion and DDAVP stimulated fibrinolysis in normolipidemic subjects.

D. Nilsen, H. Arnesen, T. Opstad, 1988, Thrombosis research.